273 related articles for article (PubMed ID: 17239010)
1. Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours.
Reed JE; Dunn JR; du Plessis DG; Shaw EJ; Reeves P; Gee AL; Warnke PC; Sellar GC; Moss DJ; Walker C
Neuropathol Appl Neurobiol; 2007 Feb; 33(1):77-85. PubMed ID: 17239010
[TBL] [Abstract][Full Text] [Related]
2. Expression of T-type calcium channel splice variants in human glioma.
Latour I; Louw DF; Beedle AM; Hamid J; Sutherland GR; Zamponi GW
Glia; 2004 Nov; 48(2):112-9. PubMed ID: 15378657
[TBL] [Abstract][Full Text] [Related]
3. [Deletion of OPCML gene and promoter methylation in ovarian epithelial carcinoma].
Zhang J; Ye F; Chen HZ; Ye DF; Lu WG; Xie X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):173-7. PubMed ID: 16733898
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
[TBL] [Abstract][Full Text] [Related]
5. Opioid-binding protein/cell adhesion molecule-like (OPCML) gene and promoter methylation status in women with ovarian cancer.
Czekierdowski A; Czekierdowska S; Szymanski M; Wielgos M; Kaminski P; Kotarski J
Neuro Endocrinol Lett; 2006 Oct; 27(5):609-13. PubMed ID: 17159813
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinoma.
Duarte-Pereira S; Paiva F; Costa VL; Ramalho-Carvalho J; Savva-Bordalo J; Rodrigues A; Ribeiro FR; Silva VM; Oliveira J; Henrique R; Jerónimo C
Eur J Cancer; 2011 May; 47(7):1106-14. PubMed ID: 21273058
[TBL] [Abstract][Full Text] [Related]
7. Hypermethylation of the RASSF1A gene in gliomas.
Gao Y; Guan M; Su B; Liu W; Xu M; Lu Y
Clin Chim Acta; 2004 Nov; 349(1-2):173-9. PubMed ID: 15469871
[TBL] [Abstract][Full Text] [Related]
8. The IgLON family in epithelial ovarian cancer: expression profiles and clinicopathologic correlates.
Ntougkos E; Rush R; Scott D; Frankenberg T; Gabra H; Smyth JF; Sellar GC
Clin Cancer Res; 2005 Aug; 11(16):5764-8. PubMed ID: 16115914
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of a novel BR-2 gene that is down-regulated in human low grade glioma tumors.
Wei KC; Berger MS; Sehgal A
Anticancer Res; 2002; 22(2A):649-57. PubMed ID: 12014633
[TBL] [Abstract][Full Text] [Related]
10. OPCML gene promoter methylation and gene expression in tumor and stroma cells of invasive cervical carcinoma.
Ye F; Zhang SF; Xie X; Lu WG
Cancer Invest; 2008 Jul; 26(6):569-74. PubMed ID: 18584347
[TBL] [Abstract][Full Text] [Related]
11. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
[TBL] [Abstract][Full Text] [Related]
12. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of human RTVP-1b, a novel splice variant of RTVP-1 in glioma cells.
Xiang C; Sarid R; Cazacu S; Finniss S; Lee HK; Ziv-Av A; Mikkelsen T; Brodie C
Biochem Biophys Res Commun; 2007 Oct; 362(3):612-8. PubMed ID: 17825796
[TBL] [Abstract][Full Text] [Related]
14. Expression of the genes of methyl-binding domain proteins in human gliomas.
Schlegel J; Güneysu S; Mennel HD
Oncol Rep; 2002; 9(2):393-5. PubMed ID: 11836615
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
[TBL] [Abstract][Full Text] [Related]
16. The aryl hydrocarbon receptor agonist 3,3',4,4',5-pentachlorobiphenyl induces distinct patterns of gene expression between hepatoma and glioma cells: chromatin remodeling as a mechanism for selective effects.
Maier MS; Legare ME; Hanneman WH
Neurotoxicology; 2007 May; 28(3):594-612. PubMed ID: 17316808
[TBL] [Abstract][Full Text] [Related]
17. TP53 promoter methylation in human gliomas.
Amatya VJ; Naumann U; Weller M; Ohgaki H
Acta Neuropathol; 2005 Aug; 110(2):178-84. PubMed ID: 16025287
[TBL] [Abstract][Full Text] [Related]
18. The PFKFB3 splice variant UBI2K4 is downregulated in high-grade astrocytomas and impedes the growth of U87 glioblastoma cells.
Zscharnack K; Kessler R; Bleichert F; Warnke JP; Eschrich K
Neuropathol Appl Neurobiol; 2009 Dec; 35(6):566-78. PubMed ID: 19490427
[TBL] [Abstract][Full Text] [Related]
19. Cloning, sequencing and expression analysis of a novel gene BR-1 that is expressed in normal human brain tissue but not in glioma tumor samples.
Wei KC; Berger MS; Sehgal A
Anticancer Res; 2002; 22(2A):745-53. PubMed ID: 12014646
[TBL] [Abstract][Full Text] [Related]
20. Effects of exogenous p53 transfection on the gene expression in the human brain glioma cell line U251.
Shu KX; Li B; Liang YL; Xie YF; Zhang JC; Wei JM
Colloids Surf B Biointerfaces; 2006 Feb; 47(2):126-31. PubMed ID: 16413759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
